Cargando…
Gas-filled ultrasound microbubbles enhance the immunoactivity of the HSP70-MAGEA1 fusion protein against MAGEA1-expressing tumours
Advanced malignant melanoma is characterized by rapid development, poor prognosis and insensitivity to chemoradiotherapy. Immunotherapy has become one of the primary clinical treatments for malignant melanomas. In recent decades, identifying specific tumour antigens and the enhanced immunoactivity o...
Autores principales: | Gao, Xing, Nan, Yang, Yuan, Yuan, Gong, Xue, Sun, Yuanyuan, Zhou, Huihui, Zong, Yujin, Zhang, Lijun, Yu, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059686/ https://www.ncbi.nlm.nih.gov/pubmed/29749485 http://dx.doi.org/10.3892/mmr.2018.9003 |
Ejemplares similares
-
Antibody response against cancer-testis antigens MAGEA4 and MAGEA10 in patients with melanoma
por: Õunap, Kadri, et al.
Publicado: (2018) -
The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex
por: Kozakova, Lucie, et al.
Publicado: (2015) -
MAGEA4 Coated Extracellular Vesicles Are Stable and Can Be Assembled In Vitro
por: Reinsalu, Olavi, et al.
Publicado: (2021) -
MAGEA11 as a STAD Prognostic Biomarker Associated with Immune Infiltration
por: Xiao, Chen, et al.
Publicado: (2022) -
Cancer/testis Antigen MAGEA3 Interacts with STAT1 and Remodels the Tumor Microenvironment
por: Wang, Ying, et al.
Publicado: (2018)